Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics on May 09-10, 2024 in Las Vegas, United States

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.

At the conclusion of this course, participants will be able to:

• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT

• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice

• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging

• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

URLs:

Tickets: https://go.evvnt.com/1875091-2?pid=10008

Virtual: https://go.evvnt.com/1875091-3?pid=10008

Time: 7:30 am - 4:45 pm

Prices:

Practicing Physician/Industry: USD 1395.00,

Military/Retired/Scientist/VA: USD 1295.00,

PA/Nurse: USD 1195.00,

Resident*/Fellow*: USD 1095.00,

Technologist: USD 995.00

Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don Yoo, MD